|
NIV reduces VAP in
acute hypoxaemic respiratory failure
|
When
compared with invasive ventilation, non-invasive ventilation for acute
hypoxaemic respiratory failure reduces the incidence of ventilator
associated pneumonia and ITU LOS.
Level of Levidence: 1+ |
Citation/s:
Massimo Antonelli, Giorgio Conti et al: A comparison of noninvasive positive
pressure ventilation and conventional mechanical ventilation inpatients with
acute respiratory failure. NEJM 1998; 339:429-435.
Lead author's name and fax: Massimo Antonelli
Three-part Clinical Question:
In intensive care patients with hypoxaemic respiratory failure, does the use of
non-invasive ventilation reduce the incidence of ventilator- associated
pneumonia as compared to conventional invasive ventilation?
Search Terms: VAP, NIV,
intensive care.
The Study: Non-blinded
randomised controlled trial with intention-to-treat.
The Study Patients: Adult patients admitted to a single ITU
with acute hypoxaemic respiratory failure over the course of 1 year. Entry
criteria were acute respiratory distress, deteriorating despite medical
management. This was defined as a respiratory rate >35, a PaO2/FiO2 ratio of
< 200mmHg while breathing oxygen from a venturi mask, using accessory muscles of
respiration. Exclusion criteria included : COPD, severe haemodynamic instability, asthma,
more than 2 new organ failures.
Control group (N = 32; 32 analysed): Initial mode of
ventilation was assist control with TV of 10ml/kg and RR 14-18, PEEP of 5 and
FiO2 0.8. PEEP was titrated upwards in increments of 2-3 cm to a maximum of 10cm
to achieve FiO2 ≤0.6. After spontaneous ventilation returned, the mode was
changed to IMV with a RR of 4-7 and pressure support at 14-20 to achieve a PS TV
of 8-10ml/kg, a RR of < 25 and disappearance of the use of accessory muscle
activity and patient comfort. Patients were weaned using a standard protocol. No
detail of sedation regimen given in the paper.
Experimental group (N = 32; 32 analysed): Full face mask
ventilation was used. Pressure support was increased to achieve an expired TV of
8-10ml/kg, a RR<25, the disappearance of accessory muscle activity. PEEP was
titrated upwards in increments of 2-3 cm to a maximum of 10cm to achieve FiO2
≤0.6. No sedation was used. The duration of ventilation was protocolized. Criteria for intubation were failure to maintain a PaO2> 65mmHg
with FiO2 of at least 0.6, requirement for airway protection (e.g. for coma), to
manage copious secretions, haemodynamic or electrocardiographic instability, or
patient intolerance of the mask. NIV was discontinued when RR<30, Pa O2>75mmHg
on FiO2 0.5 with no ventilatory support.
The Evidence:
|
Outcome |
Time to Outcome |
CER |
EER |
RRR |
ARR |
NNT |
|
Pneumonia (BAL to confirm diagnosis if clinical manifestations) |
|
0.250 |
0.031 |
88% |
0.219 |
5 |
|
95% Confidence Intervals: |
23% to 100% |
0.057 to 0.381 |
3 to 17 |
|
Sepsis |
|
0.344 |
0.188 |
45% |
0.156 |
NS |
|
95% Confidence Intervals: |
∞ |
∞ |
∞ |
|
Hospital Mortality |
|
0.500 |
0.3125 |
38% |
0.188 |
NS |
|
95% Confidence Intervals: |
∞ |
∞ |
∞ |
|
Non-Event Outcomes |
Time to outcome/s |
Control group |
Experimental group |
P-value |
|
ITU length of
stay (days) |
ICU discharge |
16 |
9 |
0.04 |
Comments:
Do the methods allow accurate testing
of the hypothesis? There is no information as to how sample size was determined.
A larger study might have resulted in significant mortality data. Although the
control group had a lower pH at enrollment, they were not acidaemic and this
probably did not affect the result.
Do the statistical tests correctly
test the results to allow differentiation of statistically significant results?
Yes
Are the conclusions valid in light of the results? Yes
Did results get omitted, and why? No
Did they suggest areas of further research? No
Did they make any recommendations based on the results and are they appropriate?
No
Is the study relevant to my clinical practice? Yes
What level of evidence does
this study represent? Level 1+
What grade of recommendation
can I make on this result alone? B
What grade of recommendation
can I make when this study is considered along with other available evidence?
N/A – single study
Should I change my practice because of these results? Yes
Should I audit my current practice because of these results? Yes – should
audit the use of NIV in these patients.
Appraised by: B Miles, Stobhill
Hospital, Glasgow; 20 May 2004
Email: barbara.miles.stob@northglasgow.scot.nhs.uk
Kill or Update By: 31 May 2006
Printer Friendly
Version
©
SICS EBM Group 2004
|